U.S. Markets closed

IDEX Reports Third Quarter Results; Delivers Record Adjusted Gross and Operating Margin; Reported EPS of $1.37 With Adjusted EPS of $1.52

LAKE FOREST, Ill.--(BUSINESS WIRE)--

IDEX Corporation (IEX) today announced its financial results for the three month period ended September 30, 2019.

Third Quarter 2019 Highlights

  • Sales were flat overall and organically
  • Gross margin was 45.2 percent with adjusted gross margin of 45.7 percent, an all-time high
  • Reported operating margin was 22.7 percent with adjusted operating margin of 25.2 percent, up 120 bps
  • Reported EPS was $1.37 with adjusted EPS of $1.52, up 8 percent
  • Cash from operations of $157.1 million led to FCF of $146.0 million, an all-time high

Third Quarter 2019

Orders of $586.1 million were down 5 percent compared with the prior year period (-5 percent organic, +1 percent acquisitions and -1 percent foreign currency translation).

Sales of $624.2 million were flat compared with the prior year period (flat organic, +1 percent acquisitions and -1 percent foreign currency translation).

Gross margin of 45.2 percent was up 20 basis points compared with the prior year period. Excluding a $3.3 million pre-tax fair value inventory step-up charge related to the Velcora acquisition, adjusted gross margin of 45.7 percent was up 70 basis points primarily due to price and productivity initiatives, partially offset by higher engineering investments.

Operating income of $141.8 million resulted in an operating margin of 22.7 percent. Excluding the $3.3 million fair value inventory step-up charge and $12.0 million of restructuring expenses, adjusted operating income was $157.1 million with an adjusted operating margin of 25.2 percent, up 120 basis points compared with the adjusted prior year period primarily due to gross margin expansion and lower variable compensation costs as well as an overall tighter cost control environment. Adjusted operating income drove adjusted EBITDA of $175.4 million which was 28 percent of sales and covered interest expense by over 15 times.

Provision for income taxes of $24.0 million in the third quarter of 2019 resulted in an effective tax rate (ETR) of 18.6 percent, which was lower than the prior year period ETR of 20.2 percent primarily due to a change in U.S. Treasury regulations as well as the mix of global pre-tax income among jurisdictions. The third quarter 2019 ETR of 18.6 percent was lower than our previously guided ETR of 22.5 percent, which provided 6 cents of EPS favorability. This was primarily due to higher excess tax benefits from greater than expected stock option exercises in the third quarter of 2019 as well as a favorable impact from the 2018 income tax return-to-provision adjustment.

Net income was $105.2 million which resulted in EPS of $1.37. Excluding the fair value inventory step-up charge and restructuring expenses, adjusted EPS was $1.52, an increase of 11 cents, or 8 percent, from the adjusted prior year period EPS.

Cash from operations of $157.1 million led to free cash flow of $146.0 million, which was up 28 percent from the prior year period and 125 percent of adjusted net income. The increase in free cash flow was primarily due to favorable operating working capital and lower capital expenditures in the third quarter of 2019.

“The third quarter was all about operational execution which allowed us to expand both gross and operating margins to all-time highs. Adjusted gross margin of 45.7 percent and adjusted operating margin of 25.2 percent were up 70 and 120 basis points, respectively. This margin expansion helped us deliver record adjusted EPS of $1.52. Free cash flow was strong with a conversion rate of 125 percent of adjusted net income, up 28 percent from the prior year period. On the commercial side, demand was challenging in the third quarter due to the continued softening of the global economy. The unresolved trade conflicts continued to weigh on global growth in most of our end markets, as companies are delaying investments due to the unclear outlook. As a result, organic sales in the third quarter were flat compared to the prior year period. However, I am very pleased with how the team performed in this challenging environment and confident that we will keep delivering strong operating results during these volatile times.

 

M&A continues to be a key priority of the Company. In July, we acquired Velcora and are currently in the process of integrating its operations into our existing Sealing Solutions platform within the Health & Science Technologies segment. We have approximately $2 billion of capacity to support additional opportunities based on existing cash, availability under our revolver and a low debt leverage ratio.

 

Based on recent order trends and instability within the macro-economic environment, we now project approximately 2 percent organic revenue growth for 2019, with flat organic sales in the fourth quarter. We have narrowed full year 2019 adjusted EPS to $5.80 to $5.82, with fourth quarter EPS of $1.33 to $1.35.”

 

 

Andrew K. Silvernail

 

Chairman and Chief Executive Officer

Third Quarter 2019 Segment Highlights

Fluid & Metering Technologies

  • Sales of $240.9 million reflected a 1 percent increase compared to the third quarter of 2018 (+2 percent organic and -1 percent foreign currency translation).
  • Operating income of $77.5 million resulted in an operating margin of 32.2 percent, a 270 basis point increase compared to the adjusted prior year period primarily due to price and productivity initiatives, partially offset by higher engineering investments.
  • EBITDA of $82.7 million resulted in an EBITDA margin of 34.3 percent, a 270 basis point increase compared to the adjusted prior year period primarily due to increased operating income.

Health & Science Technologies

  • Sales of $229.6 million reflected a 3 percent increase compared to the third quarter of 2018 (+1 percent organic, +3 percent acquisition and -1 percent foreign currency translation).
  • Operating income of $40.2 million resulted in an operating margin of 17.5 percent. Excluding the $3.3 million fair value inventory step-up charge and $11.2 million of restructuring expenses, adjusted operating income was $54.7 million with an adjusted operating margin of 23.8 percent, a 30 basis point increase compared to the adjusted prior year period primarily due to higher volume and price, partially offset by higher engineering investments and increased amortization due to the acquisition.
  • EBITDA of $49.2 million resulted in an EBITDA margin of 21.4 percent. Excluding the $3.3 million fair value inventory step-up charge and $11.2 million of restructuring expenses, adjusted EBITDA of $63.7 million resulted in an adjusted EBITDA margin of 27.8 percent, a 40 basis point increase compared to the adjusted prior year period primarily due to increased operating income.

Fire & Safety/Diversified Products

  • Sales of $154.5 million reflected a 5 percent decrease compared to the third quarter of 2018 (-3 percent organic and -2 percent foreign currency translation) mainly attributable to large project orders within our dispensing and fire businesses in the prior year period not repeating.
  • Operating income of $42.0 million resulted in an operating margin of 27.2 percent. Excluding $0.1 million of restructuring expenses, adjusted operating income was $42.1 million with an adjusted operating margin of 27.2 percent, a 50 basis point decrease compared to the adjusted prior year period primarily due to reduced volume.
  • EBITDA of $45.6 million resulted in an EBITDA margin of 29.5 percent. Excluding $0.1 million of restructuring expenses, adjusted EBITDA of $45.7 million resulted in an adjusted EBITDA margin of 29.6 percent, a 10 basis point decrease compared to the adjusted prior year period primarily due to a decrease in operating income.

For the third quarter of 2019, Fluid & Metering Technologies contributed 38 percent of sales, 49 percent of operating income and 47 percent of EBITDA; Health & Science Technologies accounted for 37 percent of sales, 25 percent of operating income and 28 percent of EBITDA; and Fire & Safety/Diversified Products represented 25 percent of sales, 26 percent of operating income and 25 percent of EBITDA.

Acquisition

In July 2019, the Company acquired Velcora Holding AB and its operating subsidiaries, Roplan and Steridose. Roplan is a global manufacturer of custom mechanical and shaft seals for a variety of end markets including food & beverage, marine, chemical, wastewater and water treatment. Steridose develops engineered hygienic mixers and valves for the global biopharmaceutical industry. With annual revenue of approximately $40 million, both businesses operate within the Health & Science Technologies segment. In connection with this acquisition, the Company had to write up inventory to its fair value which resulted in a $3.3 million fair value inventory step-up charge in the quarter.

Restructuring Actions

The Company recorded $12.0 million and $14.1 million of restructuring expenses in the third quarter and nine months ended September 30, 2019, respectively, as part of initiatives that supported the implementation of key strategic efforts designed to facilitate long-term, sustainable growth through cost reduction actions, primarily consisting of employee reductions, facility rationalization and impairment charges. These restructuring actions included a $9.7 million impairment charge in the third quarter related to the winding down of a business within the Health & Science Technologies segment.

Non-U.S. GAAP Measures of Financial Performance

The Company supplements certain U.S. GAAP financial performance metrics with non-U.S. GAAP financial performance metrics in order to provide investors with better insight and increased transparency while also allowing for a more comprehensive understanding of the financial information used by management in its decision making. Reconciliations of non-U.S. GAAP financial performance metrics to their most comparable U.S. GAAP financial performance metrics are defined and presented below and should not be considered a substitute for, nor superior to, the financial data prepared in accordance with U.S. GAAP. There were no adjustments to U.S. GAAP financial performance metrics other than the items noted below.

  • Organic orders and sales are calculated excluding amounts from acquired or divested businesses during the first twelve months of ownership or divestiture and the impact of foreign currency translation.
  • Adjusted gross margin is calculated as gross margin plus the fair value inventory step-up charge.
  • Adjusted operating income is calculated as operating income plus the fair value inventory step-up charge plus restructuring expenses.
  • Adjusted operating margin is calculated as adjusted operating income divided by net sales.
  • Adjusted net income is calculated as net income plus the fair value inventory step-up charge plus restructuring expenses, net of the statutory tax expense or benefit.
  • EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. We reconciled EBITDA to net income on a consolidated basis as we do not allocate consolidated interest expense or consolidated provision for income taxes to our segments.
  • Adjusted EBITDA is calculated as EBITDA plus the fair value inventory step-up charge plus restructuring expenses.
  • Free cash flow is calculated as cash flow from operating activities less capital expenditures.

Table 1: Reconciliations of the Change in Net Sales to Organic Net Sales

 

Three Months Ended September 30, 2019

 

Nine Months Ended September 30, 2019

 

FMT

 

HST

 

FSDP

 

IDEX

 

FMT

 

HST

 

FSDP

 

IDEX

Change in net sales

1

%

 

3

%

 

(5

)%

 

%

 

2

%

 

2

%

 

(2

)%

 

1

%

- Net impact from acquisitions

%

 

3

%

 

%

 

1

%

 

%

 

2

%

 

%

 

1

%

- Impact from FX

(1

)%

 

(1

)%

 

(2

)%

 

(1

)%

 

(2

)%

 

(2

)%

 

(2

)%

 

(2

)%

Change in organic net sales

2

%

 

1

%

 

(3

)%

 

%

 

4

%

 

2

%

 

%

 

2

%

Table 2: Reconciliations of Reported-to-Adjusted Gross Profit and Margin (dollars in thousands)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2019

 

2018

 

2019

 

2018

Gross profit

$

281,978

 

 

$

280,233

 

 

$

858,149

 

 

$

844,252

 

+ Fair value inventory step-up charge

3,340

 

 

 

 

3,340

 

 

 

Adjusted gross profit

$

285,318

 

 

$

280,233

 

 

$

861,489

 

 

$

844,252

 

 

 

 

 

 

 

 

 

Net sales

$

624,246

 

 

$

622,888

 

 

$

1,888,576

 

 

$

1,869,572

 

 

 

 

 

 

 

 

 

Gross profit margin

45.2

%

 

45.0

%

 

45.4

%

 

45.2

%

Adjusted gross profit margin

45.7

%

 

45.0

%

 

45.6

%

 

45.2

%

Table 3: Reconciliations of Reported-to-Adjusted Operating Income and Margin (dollars in thousands)

 

Three Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

77,481

 

 

$

40,170

 

 

$

41,967

 

 

$

(17,853

)

 

$

141,765

 

 

$

69,755

 

 

$

49,144

 

 

$

44,726

 

 

$

(18,492

)

 

$

145,133

 

+ Restructuring expenses

 

 

11,196

 

 

104

 

 

656

 

 

11,956

 

 

827

 

 

3,116

 

 

60

 

 

618

 

 

4,621

 

+ Fair value inventory step-up charge

 

 

3,340

 

 

 

 

 

 

3,340

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating income (loss)

$

77,481

 

 

$

54,706

 

 

$

42,071

 

 

$

(17,197

)

 

$

157,061

 

 

$

70,582

 

 

$

52,260

 

 

$

44,786

 

 

$

(17,874

)

 

$

149,754

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

240,861

 

 

$

229,610

 

 

$

154,543

 

 

$

(768

)

 

$

624,246

 

 

$

239,213

 

 

$

222,426

 

 

$

161,832

 

 

$

(583

)

 

$

622,888

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

32.2

%

 

17.5

%

 

27.2

%

 

n/m

 

22.7

%

 

29.2

%

 

22.1

%

 

27.6

%

 

n/m

 

23.3

%

Adjusted operating margin

32.2

%

 

23.8

%

 

27.2

%

 

n/m

 

25.2

%

 

29.5

%

 

23.5

%

 

27.7

%

 

n/m

 

24.0

%

 

Nine Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

223,493

 

 

$

151,087

 

 

$

125,909

 

 

$

(55,659

)

 

$

444,830

 

 

$

207,149

 

 

$

153,519

 

 

$

130,162

 

 

$

(61,183

)

 

$

429,647

 

+ Restructuring expenses

930

 

 

11,526

 

 

923

 

 

703

 

 

14,082

 

 

1,313

 

 

5,298

 

 

427

 

 

1,213

 

 

8,251

 

+ Fair value inventory step-up charge

 

 

3,340

 

 

 

 

 

 

3,340

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating income (loss)

$

224,423

 

 

$

165,953

 

 

$

126,832

 

 

$

(54,956

)

 

$

462,252

 

 

$

208,462

 

 

$

158,817

 

 

$

130,589

 

 

$

(59,970

)

 

$

437,898

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

729,572

 

 

$

687,153

 

 

$

474,745

 

 

$

(2,894

)

 

$

1,888,576

 

 

$

714,346

 

 

$

670,904

 

 

$

485,305

 

 

$

(983

)

 

$

1,869,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

30.6

%

 

22.0

%

 

26.5

%

 

n/m

 

23.6

%

 

29.0

%

 

22.9

%

 

26.8

%

 

n/m

 

23.0

%

Adjusted operating margin

30.8

%

 

24.2

%

 

26.7

%

 

n/m

 

24.5

%

 

29.2

%

 

23.7

%

 

26.9

%

 

n/m

 

23.4

%

Table 4: Reconciliations of Reported-to-Adjusted Net Income and EPS (in thousands, except EPS)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2019

 

2018

 

2019

 

2018

Reported net income

$

105,194

 

 

$

106,352

 

 

$

328,671

 

 

$

312,436

 

+ Restructuring expenses

11,956

 

 

4,621

 

 

14,082

 

 

8,251

 

+ Tax impact on restructuring expenses

(2,776

)

 

(1,130

)

 

(3,336

)

 

(2,003

)

+ Fair value inventory step-up charge

3,340

 

 

 

 

3,340

 

 

 

+ Tax impact on fair value inventory step-up charge

(735

)

 

 

 

(735

)

 

 

Adjusted net income

$

116,979

 

 

$

109,843

 

 

$

342,022

 

 

$

318,684

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2019

 

2018

 

2019

 

2018

Reported diluted EPS

$

1.37

 

 

$

1.37

 

 

$

4.30

 

 

$

4.02

 

+ Restructuring expenses

0.16

 

 

0.06

 

 

0.18

 

 

0.11

 

+ Tax impact on restructuring expenses

(0.04

)

 

(0.02

)

 

(0.04

)

 

(0.03

)

+ Fair value inventory step-up charge

0.04

 

 

 

 

0.04

 

 

 

+ Tax impact on fair value inventory step-up charge

(0.01

)

 

 

 

(0.01

)

 

 

Adjusted diluted EPS

$

1.52

 

 

$

1.41

 

 

$

4.47

 

 

$

4.10

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

76,577

 

 

77,709

 

 

76,415

 

 

77,717

 

Table 5: Reconciliations of EBITDA to Net Income (dollars in thousands)

 

Three Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

77,481

 

 

$

40,170

 

 

$

41,967

 

 

$

(17,853

)

 

$

141,765

 

 

$

69,755

 

 

$

49,144

 

 

$

44,726

 

 

$

(18,492

)

 

$

145,133

 

- Other (income) expense - net

295

 

 

1,272

 

 

(92

)

 

(256

)

 

1,219

 

 

411

 

 

780

 

 

342

 

 

(599

)

 

934

 

+ Depreciation and amortization

5,507

 

 

10,296

 

 

3,566

 

 

154

 

 

19,523

 

 

5,500

 

 

9,381

 

 

3,541

 

 

184

 

 

18,606

 

EBITDA

82,693

 

 

49,194

 

 

45,625

 

 

(17,443

)

 

160,069

 

 

74,844

 

 

57,745

 

 

47,925

 

 

(17,709

)

 

162,805

 

- Interest expense

 

 

 

 

 

 

 

 

11,330

 

 

 

 

 

 

 

 

 

 

10,958

 

- Provision for income taxes

 

 

 

 

 

 

 

 

24,022

 

 

 

 

 

 

 

 

 

 

26,889

 

- Depreciation and amortization

 

 

 

 

 

 

 

 

19,523

 

 

 

 

 

 

 

 

 

 

18,606

 

Reported net income

 

 

 

 

 

 

 

 

$

105,194

 

 

 

 

 

 

 

 

 

 

$

106,352

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

240,861

 

 

$

229,610

 

 

$

154,543

 

 

$

(768

)

 

$

624,246

 

 

$

239,213

 

 

$

222,426

 

 

$

161,832

 

 

$

(583

)

 

$

622,888

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

32.2

%

 

17.5

%

 

27.2

%

 

n/m

 

22.7

%

 

29.2

%

 

22.1

%

 

27.6

%

 

n/m

 

23.3

%

EBITDA margin

34.3

%

 

21.4

%

 

29.5

%

 

n/m

 

25.6

%

 

31.3

%

 

26.0

%

 

29.6

%

 

n/m

 

26.1

%

 

Nine Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

Reported operating income (loss)

$

223,493

 

 

$

151,087

 

 

$

125,909

 

 

$

(55,659

)

 

$

444,830

 

 

$

207,149

 

 

$

153,519

 

 

$

130,162

 

 

$

(61,183

)

 

$

429,647

 

- Other (income) expense - net

612

 

 

1,636

 

 

273

 

 

(1,820

)

 

701

 

 

1,056

 

 

(280

)

 

(3,324

)

 

(1,017

)

 

(3,565

)

+ Depreciation and amortization

16,653

 

 

29,438

 

 

10,745

 

 

510

 

 

57,346

 

 

16,901

 

 

30,860

 

 

10,912

 

 

557

 

 

59,230

 

EBITDA

239,534

 

 

178,889

 

 

136,381

 

 

(53,329

)

 

501,475

 

 

222,994

 

 

184,659

 

 

144,398

 

 

(59,609

)

 

492,442

 

- Interest expense

 

 

 

 

 

 

 

 

33,262

 

 

 

 

 

 

 

 

 

 

33,098

 

- Provision for income taxes

 

 

 

 

 

 

 

 

82,196

 

 

 

 

 

 

 

 

 

 

87,678

 

- Depreciation and amortization

 

 

 

 

 

 

 

 

57,346

 

 

 

 

 

 

 

 

 

 

59,230

 

Reported net income

 

 

 

 

 

 

 

 

$

328,671

 

 

 

 

 

 

 

 

 

 

$

312,436

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (eliminations)

$

729,572

 

 

$

687,153

 

 

$

474,745

 

 

$

(2,894

)

 

$

1,888,576

 

 

$

714,346

 

 

$

670,904

 

 

$

485,305

 

 

$

(983

)

 

$

1,869,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating margin

30.6

%

 

22.0

%

 

26.5

%

 

n/m

 

23.6

%

 

29.0

%

 

22.9

%

 

26.8

%

 

n/m

 

23.0

%

EBITDA margin

32.8

%

 

26.0

%

 

28.7

%

 

n/m

 

26.6

%

 

31.2

%

 

27.5

%

 

29.8

%

 

n/m

 

26.3

%

Table 6: Reconciliations of EBITDA to Adjusted EBITDA (dollars in thousands)

 

Three Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

EBITDA

$

82,693

 

 

$

49,194

 

 

$

45,625

 

 

$

(17,443

)

 

$

160,069

 

 

$

74,844

 

 

$

57,745

 

 

$

47,925

 

 

$

(17,709

)

 

$

162,805

 

+ Restructuring expenses

 

 

11,196

 

 

104

 

 

656

 

 

11,956

 

 

827

 

 

3,116

 

 

60

 

 

618

 

 

4,621

 

+ Fair value inventory step-up charge

 

 

3,340

 

 

 

 

 

 

3,340

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

82,693

 

 

$

63,730

 

 

$

45,729

 

 

$

(16,787

)

 

$

175,365

 

 

$

75,671

 

 

$

60,861

 

 

$

47,985

 

 

$

(17,091

)

 

$

167,426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA margin

34.3

%

 

27.8

%

 

29.6

%

 

n/m

 

28.1

%

 

31.6

%

 

27.4

%

 

29.7

%

 

n/m

 

26.9

%

...

 

Nine Months Ended September 30,

 

2019

 

2018

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

 

FMT

 

HST

 

FSDP

 

Corporate

 

IDEX

EBITDA

$

239,534

 

 

$

178,889

 

 

$

136,381

 

 

$

(53,329